Antonio Marchetti
Antonio Marchetti
Email verificata su
Citata da
Citata da
EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening …
A Marchetti, C Martella, L Felicioni, F Barassi, S Salvatore, A Chella, ...
Journal of clinical oncology 23 (4), 857-865, 2005
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis
G D'Orazi, B Cecchinelli, T Bruno, I Manni, Y Higashimoto, S Saito, ...
Nature cell biology 4 (1), 11-19, 2002
Increased MET gene copy number negatively affects survival of surgically resected non–small-cell lung cancer patients
F Cappuzzo, A Marchetti, M Skokan, E Rossi, S Gajapathy, L Felicioni, ...
Journal of Clinical Oncology 27 (10), 1667, 2009
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
A Marchetti, L Felicioni, S Malatesta, M Grazia Sciarrotta, L Guetti, ...
Journal of clinical oncology 29 (26), 3574-3579, 2011
IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors
FE Bleeker, S Lamba, S Leenstra, D Troost, T Hulsebos, WP Vandertop, ...
Human mutation 30 (1), 7-11, 2009
Survivin gene expression in early‐stage non‐small cell lung cancer
M Falleni, C Pellegrini, A Marchetti, B Oprandi, F Buttitta, F Barassi, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crinò, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ...
Journal of Thoracic Oncology 5 (10), 1706-1713, 2010
The Hippo effector YAP promotes resistance to RAF-and MEK-targeted cancer therapies
L Lin, AJ Sabnis, E Chan, V Olivas, L Cade, E Pazarentzos, S Asthana, ...
Nature genetics 47 (3), 250-256, 2015
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer
R Cazzoli, F Buttitta, M Di Nicola, S Malatesta, A Marchetti, WN Rom, ...
Journal of thoracic oncology 8 (9), 1156-1162, 2013
Association between cigarette smoking and FHIT gene alterations in lung cancer
G Sozzi, L Sard, L De Gregorio, A Marchetti, K Musso, F Buttitta, ...
Cancer research 57 (11), 2121-2123, 1997
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ...
Annals of Oncology 25 (9), 1681-1690, 2014
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Péchoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
Assessing EGFR mutations.
A Marchetti, L Felicioni, F Buttitta
The New England journal of medicine 354 (5), 526-8; author reply 526, 2006
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, P Meldgaard, M Nicolson, L Paz-Ares, M Reck, ...
Annals of Oncology 25 (8), 1475-1484, 2014
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ...
Clinical Cancer Research 13 (20), 6064-6069, 2007
p53 inhibits α6β4 integrin survival signaling by promoting the caspase 3–dependent cleavage of AKT/PKB
RE Bachelder, MJ Ribick, A Marchetti, R Falcioni, S Soddu, KR Davis, ...
The Journal of cell biology 147 (5), 1063-1072, 1999
AKT1 E17K in human solid tumours
FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ...
Oncogene 27 (42), 5648-5650, 2008
Cooperative Signaling between α6β4Integrin and ErbB-2 Receptor Is Required to Promote Phosphatidylinositol 3-Kinase-dependent Invasion
D Gambaletta, A Marchetti, L Benedetti, AM Mercurio, A Sacchi, R Falcioni
Journal of Biological Chemistry 275 (14), 10604-10610, 2000
Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways
N Shukla, N Ameur, I Yilmaz, K Nafa, CY Lau, A Marchetti, L Borsu, ...
Clinical Cancer Research 18 (3), 748-757, 2012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20